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The proliferating cell nuclear antigen (PCNA) is a
highly conserved protein required for the assembly of
the DNA polymerase delta (pol d) holoenzyme. Because
PCNAs from Saccharomyces cerevisiae and human do
not complement each other using in vitro or in vivo
assays, hybrids of the two proteins would help identify
region(s) involved in the assembly of the pol d holoen-
zyme. Two mutants of human PCNA, HU1 (D21E) and
HU3 (D120E), and six hybrids of human and S. cerevisiae
PCNA, HC1, HC5, CH2, CH3, CH4, and CH5, were pre-
pared by swapping corresponding regions between the
two proteins. In solution, all PCNA assembled into trim-
ers, albeit to different extents. These PCNA variants
were tested for stimulation of pol d and in vitro replica-
tion of M13 and SV40 DNA as well as to stimulate the
ATPase activity of replication factor C (RF-C). Our data
suggest that in addition to the interdomain connecting
loop and C terminus, an additional site in the N termi-
nus is required for pol d interaction. PCNA mutants and
hybrids that stimulated pol d and RF-C were deficient in
M13 and SV40 DNA replication assays, indicating that
PCNA-induced pol d stimulation and RF-C-mediated
loading are not sufficient for coordinated DNA synthesis
at a replication fork.
DNA replication is a fundamental biological process that is
vital for cell proliferation. The mechanism of DNA synthesis
and its regulation is highly complex requiring the interplay of
many proteins that cooperate to duplicate the genetic informa-
tion for the next generation rapidly and accurately (1–4). Fac-
tors required for DNA replication in eukaryotes have been
identified using replication of simian virus 40 (SV40) as a
model system because all of the proteins required for SV40,
except the viral large T antigen, are host-provided (5–7). Sys-
tematic reconstitution of SV40 replication in vitro using highly
purified proteins has provided important insights into their
functions (8). Our current understanding of DNA replication in
eukaryotes suggests that polymerase a (pol1 a)2primase syn-
thesizes the first RNA/DNA primer on the leading strand
which is then followed by the binding of RF-C and loading of
PCNA and a polymerase switch from pol a to pol d. Thus pol d
holoenzyme performs processive leading strand synthesis,
whereas pol a participates in RNA priming and lagging strand
synthesis. However, complete synthesis of Okazaki fragments
also requires participation of pol d holoenzyme (9–15).
A vital element of the DNA replication machinery is the
ability of DNA pol d to execute processive DNA synthesis al-
lowing the polymerase to move quickly along the template
thousands of nucleotides without dissociation. This is accom-
plished in Escherichia coli by the b subunit of DNA pol III and
in eukaryotes by PCNA, which is a processivity factor for pol d
(16). The crystal structure of the b subunit and PCNA showed
a toroidal structure that can encircle the DNA (17, 18). PCNA
is a homotrimer in which each subunit consists of two struc-
turally related domains giving the molecule a 6-fold symmetry.
The center of the ring is positively charged, and it is large
enough to allow free passage of double-stranded DNA. PCNA is
loaded onto DNA by the action of RF-C (11, 19), a complex of
five different subunits (20, 21), in an ATP-dependent manner.
The RF-CzPCNA complex then tethers pol d onto the template
to assemble a highly processive pol dzPCNAzRF-C complex also
known as the pol d holoenzyme. However, in the absence of
RF-C, PCNA can still load onto linear DNA at a double-
stranded end, albeit at much lower efficiency (22). The orien-
tation of the PCNA ring provides two surfaces, one facing the
primer-template junction required for pol d and RF-C binding
and the other surface facing the double-stranded DNA for
binding of other proteins (23, 24). The molecular interactions
between different subunits of various proteins in the holoen-
zyme have only been partially studied.
Besides being required for coordinated leading and lagging
strand DNA synthesis at a replication fork (25), PCNA has also
been implicated in a variety of cellular processes such as cell
cycle control (26), nucleotide excision repair (27, 28), postrep-
lication mismatch repair (29, 30), base excision repair (31),
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chromatin function (32–34), RNA transcription, and cytosine-5
methylation (35) (for reviews see Refs. 2, 4, 20, 36). PCNA
therefore not only acts as a clamp for DNA polymerases, but it
is also a multifunctional protein that may link multiple pro-
tein-protein interactions in replication, repair, recombination,
and cell cycle regulation.
The primary structure of PCNA is highly conserved in the
animal kingdom (31, 37, 38), and related proteins have been
found in plant (39), yeast (40, 41), and virus (42). Recent mu-
tation analyses of both human and yeast PCNA have shown
that PCNA is remarkably resistant to amino acid substitution,
but these studies have defined protein interaction sites on the
surface of PCNA (23, 43–51). However, deletions in any part of
the molecule including the N and C termini distort the tertiary
structure, rendering the protein of limited use in functional
assays. The Saccharomyces cerevisiae homolog of PCNA, pol30,
shares 35% sequence identity with the human PCNA (hPCNA)
and is able to enhance the processivity of the mammalian pol d
(52), but it is unable to complement hPCNA in SV40 DNA
replication in vitro (53). This suggests that S. cerevisiae PCNA
(cPCNA) has very low affinity for mammalian pol d and RF-C,
even though both yeast and mammalian PCNAs exist as trim-
ers (54, 55). We therefore argued that by swapping different
regions between h- and cPCNA, it should be possible to gener-
ate hybrids that were equivalent to large deletions in hPCNA
while retaining a trimeric structure. Functional analyses of
these hybrids would help to define region(s) of hPCNA involved
in DNA replication.
We introduced mutations in the highly conserved region of
PCNA and also generated a set of novel human-S. cerevisiae
PCNA hybrids. These PCNAs were examined for their ability to
stimulate pol d and RF-C or to function in DNA replication
assays. The stimulation of RF-C and pol d involves associations
on at least three sites located at the N and C termini, and at the
interdomain connector (IDC) loop of PCNA. We have observed
induction of RF-C-catalyzed ATPase activity by a PCNA hybrid
that was predominantly dimeric, suggesting that PCNA trim-
ers may not be necessary for stimulation of RF-C ATPase. Our
data also suggest that assembly of the pol d holoenzyme may
require participation of other proteins at a replication fork.
EXPERIMENTAL PROCEDURES
Materials—Restriction and DNA-modifying enzymes were obtained
from Roche Molecular Biochemicals (Germany) and from Promega.
Radioactive chemicals were bought from Amersham Pharmacia Biotech
and ICN (U. K.). Synthetic oligonucleotides were supplied by Imperial
Cancer Research Fund laboratories, U. K., and purified by urea-PAGE
before use. (dA)290–539 and oligo(dT)12–18 were obtained from Amersham
Pharmacia Biotech. The 69-nucleotide hairpin DNA used in the RF-C
stimulation assay was constructed by ligating two oligonucleotides fol-
lowing the method described previously (9). Singly primed M13 DNA,
M13mp18, was prepared according to the method described earlier (56).
Anti-PCNA antibodies, PC-9 and PC-10, were obtained by growing
respective hybridomas in Dulbecco’s modified Eagle’s medium 1 10%
fetal calf serum. Supernatants from the confluent cultures were stored
in 0.2% (w/v) sodium azide until used. All other chemicals and reagents
used in this study were molecular biology grade and were obtained from
BDH/Merck and Sigma.
Plasmid pSV011 was constructed by ligating a HindIII-SphI frag-
ment containing the SV40 origin of replication into pUC18 as described
earlier (25), and the construct was purified by Triton X-100 lysis of
recombinant bacteria followed by CsCl gradient centrifugation. Con-
struction of plasmids for the expression of the human, pThPCNA, and
S. cerevisiae, pTyPCNA, PCNA has been described previously (41, 53).
Preparation of Replication Proteins—DNA pol d from calf thymus,
RPA from E. coli, and SV40 large T antigen from Sf9 insect cells
infected with recombinant baculovirus were purified as described pre-
viously (15). Human RF-C was expressed and purified from baculovirus
infected Sf9 cells as described earlier (57). The cytosolic replication
extract (S100) from human 293 cells was prepared as described (7).
Fractionation of S100 into fractions II and IA has been described pre-
viously (16). Fraction II contained multiple components including DNA
polymerases a and d, RF-C, topoisomerases I and II, DNA ligases, and
other essential DNA replication proteins; RPA was the main component
of fraction IA (9, 16, 58–60).
Site-directed Mutagenesis and Preparation of Human-S. cerevisiae
PCNA Hybrids—Mutations were introduced into the respective cDNA
for the wild type (wt) h- and cPCNA using the plasmid pThPCNA and
pTyPCNA by polymerase chain reaction-mediated site-directed mu-
tagenesis using the Quick Change mutagenesis kit (Stratagene) accord-
ing to the manufacturer’s instructions. The primers used for generating
mutants and the restriction sites created are shown in Table I. Four
human and five S. cerevisiae PCNA mutants were prepared using this
method. The mutations were confirmed by nucleotide sequencing.
The mutant cDNAs for h- and cPCNA were subjected to double
restriction enzyme digestion using the restriction sites created during
mutagenesis (see Table I) and the BamHI site present at the 39-end in
all constructs. The insert and vector DNAs were ligated in different
combinations such that the hPCNA inserts were swapped with the
corresponding segment of cPCNA. This resulted in 10 different con-
structs containing part of the hPCNA fused with a part of cPCNA (see
Table II), which were confirmed by nucleotide sequencing. The hybrids
were named by two letters followed by a number in which the first letter
was derived from the species contributing the N terminus followed by
the species contributing the C terminus. For example, hybrids with the
human sequence at the N terminus were named HC whereas those with
S. cerevisiae sequence at their N terminus were named as CH. The
contribution of the two PCNAs in each hybrid is shown in Table II.
Expression and Purification of Recombinant PCNA—Plasmids con-
structs encoding wt, mutant, and hybrid PCNA were transformed into
BL21(DE3) cells for expression of protein. An overnight culture (0.75
ml) was used to inoculate 200 ml of LB 1 ampicillin and grown at 37 °C
until A600 reached to 0.6. The protein expression was induced with 1 mM
isopropyl-1-thio-b-D-galactopyranoside and grown for 3–6 h at 37 °C.
TABLE I
Sequence of oligonucleotides used in site-directed mutagenesis of h- and cPCNA
Mutants Restrictionsite created Oligonucleotide used in mutagenesis 59 3 39
a Mutationsb
HU1 Sac I GGAGGCACTCAAGGAGCTCATCAACGAGG D21E
HU2 Spe I CGTGAACCTCACTAGTATGTCCAAA c219 3 t
HU3 Sac I AGTTGATGGAGCTCGATGTTGAAC D120E
HU4 Sac I CAAGTGGAGAGCTCGGAAATGGAA a522 3 g
t525 3 c
CE1 Sac I GTTTCAAAGAGCTCGTCCAGTTGG D21E; C22L
CE2 Spe I GGTATGGATCTAACTAGTCTAAGTAAAATCC c219 3 t
t220 3 a
c221 3 g
a222 3 t
CE3 Sac I CTGAAATTGATGGAGCTCGATGCTGATTTC I121L
CE4 Sac I GTAGCTGACGGTGAGCTCGGATCAGGTTC D174E; I175L
CE5 Kpn I GACGTTCGGAGCTAGGTACCTATTGGACATCA L210R
t633 3 c
t634 3 c
a Underlined nucleotides are those mutated from the wt sequence.
b Amino acid replacements are shown in upper case, and nucleotide changes are in lower case.
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The procedure for extraction and purification of PCNA from recom-
binant bacteria was carried out at 4 °C. Bacteria from 200-ml cultures
were harvested at 3,000 rpm for 15 min, resuspended into 4 ml of lysis
buffer (25 mM Tris-HCl, pH 7.4, 25 mM NaCl, 1 mM EDTA, 0.01%
Nonidet P-40, 2 mM benzamidine, 2 mM pepstatin A, 10 mM NaHSO3, 1
mM phenylmethylsulfonyl fluoride, and 1 mM DTT), and sonicated to
disrupt cells and reduce viscosity. The mixture was adjusted to 0.2 M
NaCl, cleared by centrifugation, and loaded onto a Q-Sepharose column
(1.2 3 11 cm) equilibrated with 0.2 M NaCl and buffer A (50 mM
Tris-HCl, pH 7.4, 20% glycerol, 2 mM EDTA, 0.02% Nonidet P-40, 2 mM
benzamidine, 2 mM pepstatin A, 10 mM NaHSO3, 1 mM phenylmethyl-
sulfonyl fluoride, and 1 mM DTT). After washing the column, bound
PCNA was eluted with a 0.2–0.7 M linear NaCl gradient in buffer A.
The PCNA-containing fractions, identified by SDS-PAGE, were pooled
and dialyzed against 25 mM KPO4, pH 7.0, and buffer B (10 mM KPO4,
pH 7.0, 10% glycerol, 0.01% Nonidet P-40, 2 mM benzamidine, 2 mM
pepstatin A, 10 mM NaHSO3, 1 mM phenylmethylsulfonyl fluoride, and
1 mM DTT) and loaded onto an S-Sepharose column (1.2 x 11 cm). The
PCNA-containing flow-through fractions were pooled and loaded onto a
hydroxyapatite column (2.5 3 11 cm) equilibrated with 25 mM KPO4
and buffer B and eluted with a 0.025–0.5 M linear phosphate gradient
in buffer B. The PCNA-containing fractions from the hydroxyapatite
column were pooled, dialyzed against 1.2 M NaCl and buffer C (50 mM
Tris-HCl, pH 7.4, 2 mM EDTA, 0.02% Nonidet P-40, 2 mM benzamidine,
2 mM pepstatin A, 10 mM NaHSO3, 1 mM phenylmethylsulfonyl fluoride,
and 1 mM DTT), and 4 ml of the sample was loaded onto a phenyl-
agarose column (1.2 3 11 cm). The protein was eluted with a decreasing
linear salt gradient from 1.2 to 0 M NaCl in buffer C, and the PCNA-
containing fractions were pooled, dialyzed against 20% sucrose, 25 mM
NaCl, and buffer A and stored in aliquots at 270 °C until used.
Electrophoresis, Immunoblotting, and Chemical Cross-linking—
SDS-PAGE of PCNA proteins was carried out on 12% polyacrylamide
gels using the conditions described elsewhere (61). Western blotting
was performed using nitrocellulose membranes as described earlier
(62). Native gel electrophoresis was carried out on 8–25% gradient gels
using the Phast System (Amersham Pharmacia Biotech) according to
the manufacturer’s recommendations.
Chemical cross-linking was carried out using ethylene glycol-bis-
succinimidyl succinate as described previously (63).
Gel Filtration Analysis—Purified wt, mutant, and hybrid PCNA
preparations (100 mg) were applied onto a Superose 12 HR10/30 (Am-
ersham Pharmacia Biotech) gel filtration column equilibrated with 25
mM Tris-HCl, pH 7.4, 5 mM EDTA, and 250 mM NaCl. The column was
calibrated by eluting a sample of blue dextran and five native molecular
mass markers, lactate dehydrogenase (145 kDa), bovine serum albumin
(66 kDa), ovalbumin (43 kDa), carbonic anhydrase (31 kDa), and cyto-
chrome c (12 kDa). The elution volume for each marker was the time
taken to elute the peak fraction of that sample. The peak fractions
(300–500 ml) for each PCNA were collected, concentrated using Centri-
con™ microconcentrators (Amicon), and the presence of PCNA was
confirmed by SDS-PAGE.
Stimulation and Processivity Assay for DNA Pol d—The DNA pol d
stimulation assay used in this study was a slightly modified version of
that described previously (12, 13). The reaction mixtures (12.5 ml)
contained 30 mM HEPES/NaOH pH 6.6 buffer, 7 mM MgCl2, 0.5 mM
DTT, 0.1 mg/ml bovine serum albumin, (dA)540, oligo(dT)16, in a ratio of
19:1 in nucleotides, 40 mM dTTP, 0.17 pmol of [a-32P]TTP, 0.15 unit of
calf thymus pol d, and different concentrations of PCNA. The reactions
were incubated at 37 °C for 15 min, and 2 ml was spotted on DE81 paper
(Whatman), washed in 0.5 M Na2HPO4, and the incorporated radioac-
tivity was measured in a scintillation counter.
The processivity assay was essentially as described above except that
the reactions contained limiting amounts of PCNA (0.5–5 ng) and
0.0075 unit of pol d in the presence of 1.7 pmol of [a-32P]TTP. The
incorporated radioactivity was determined as described above, and the
rest of the reaction mixture was analyzed on a 2% alkaline agarose gel
and visualized by autoradiography.
RF-C ATPase Assays—RF-C ATPase activity was measured accord-
ing to a protocol described previously (57). The reaction mixture (20 ml)
contained 30 mM HEPES pH 7.5 buffer, 7 mM MgCl2, 0.5 mM DTT, 0.1
mg/ml bovine serum albumin, 100 mM ATP, 3 pmol of [a-32P]ATP (800
Ci/mmol), 0.25 pmol of RF-C, 0.4 mmol of hairpin DNA with 59-single-
strand extension, and different concentrations of PCNA. The reaction
mixtures were incubated for 1 h at 37 °C and stopped by 10 mM EDTA.
One-tenth (2 ml) of the reaction mixture was spotted onto a polyethyl-
eneimine-cellulose plate that had been pretreated with 1 M formic acid.
The plates were then developed in a mixture of 1 M formic acid and 0.5
M LiCl for 60 min. After autoradiography the amount of ADP produced
was determined by scanning the plates on a Storm 860 PhosphorImager
(Molecular Dynamics).
DNA Replication Assays—M13 DNA synthesis reactions were car-
ried out by incubating singly primed M13mp18 DNA with pol d, RF-C,
PCNA, and RPA as described previously (56).
The SV40 DNA replication assays in vitro were performed as de-
scribed previously (16) using S100, fraction IA, fraction II, large T
antigen, and SV40 origin of replication containing plasmid, pSV011.
The optimal amounts of extracts and proteins required in the assay
were determined empirically by titration. Reaction mixtures were as-
sembled using PCNA, pSV011, fractions IA and II, large T antigen,
nucleotide mixture, and creatine phosphate/creatine phosphokinase on
ice. The samples were incubated at 37 °C for 1 h; the controls were left
on ice. After terminating the reaction with 20 mM EDTA, the 32P
incorporation was determined using DE81 paper. The remaining por-
tion of the reaction mixture from either M13 or SV40 assay was depro-
teinated with proteinase K and extracted with phenol/chloroform. After
precipitating with ethanol, the replication products were analyzed on
an agarose gel, fixed in a mixture of 10% methanol 1 10% acetic acid,
dried, and autoradiographed.
Other Methods—The techniques used for genetic manipulation of
bacteria were performed using standard protocols (64). Protein concen-
trations were determined by the BCA method (Sigma) using BSA as
standard. Nuclease contamination in PCNA preparations was tested by
incubating each PCNA protein (20 ng–2 mg) with 1 mg of pGEX-2T for
1 h at 37 °C followed by separation on an agarose gel. All gel pictures
and blots were scanned and assembled using the Adobe PhotoShop
version 5.
RESULTS
Expression and Purification of PCNA Mutants and Hy-
brids—We have produced 4 hPCNA (HU) and 5 cPCNA (CE)
mutants, each bearing a mutation that created a unique re-
striction site within the coding region (Table I). The sites for
mutation were selected, as far as possible, to fall in the region
connecting different b sheets or a helices. Two of the hPCNA
mutants, HU2 and HU4, had silent mutations and were used
only for making hybrids; the other two, HU1, containing the
mutation D21E in the A1B1 loop on the inner surface of the
trimer, and HU3, containing the mutation D120E at the begin-
ning of the IDC loop, were conservative changes. These mu-
tants and hybrids were employed in functional analyses,
whereas the cPCNA mutants were used only for preparing
hybrids.
The pThPCNA and pTyPCNA plasmids expressing h- and
cPCNA, respectively, were used in site-directed mutagenesis as
described under “Experimental Procedures.” The predicted
structure of the hybrids is shown in Fig. 1 and Table II. The
relative mobility of the wt h- and cPCNA on SDS-PAGE yielded
an apparent molecular mass of 36 kDa and 29 kDa, respec-
tively. The wt hPCNA, HU1, and HU3 had identical mobility on
SDS-PAGE, whereas the electrophoretic mobilities of the hy-
brids varied between that of wt h- and cPCNA (Fig. 2). All
constructs produced soluble PCNA proteins when grown in
bacteria on a smaller scale; however, when a large scale cul-
tures were employed, four of the constructs, HC2, HC3, HC4,
and CH1, lost their ability to produce soluble protein effi-
TABLE II
Contribution of the h- and cPCNA in different hybrids used in this
study along with the origin of IDC loop
PCNA
hybrids
Contribution from
hPCNA
Contribution from
cPCNA Origin of IDC loop
a
amino acids amino acids
HC1 1–20 21–258 S. cerevisiae
HC5 1–211 212–258 Human
CH2 73–261 1–72 Human
CH3 121–261 1–120 12% S. cerevisiae
88% Human
CH4 175–261 1–174 S. cerevisiae
CH5 212–261 1–211 S. cerevisiae
a IDC loop extends from residues 118 to 135.
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ciently, which could have been the result of inclusion body
formation. These constructs were therefore excluded from this
study.
Soluble PCNA extracted from large scale cultures were pu-
rified to near homogeneity as judged by silver staining of SDS-
PAGE gels (Fig. 2). Starting from a 200-ml culture, the yield of
purified PCNA was 1–2 mg from different constructs except for
HU3 and CH4, which gave only 400 and 360 mg of purified
protein, respectively. The lower yield of CH4 could be caused by
the aggregation tendency of this hybrid as reported for other
mutants (23, 45); however, the same did not apply to HU3 that
was predominantly trimeric in solution (see Fig. 3). These
preparations were free of nucleases because no degradation of
plasmid DNA was observed by up to 200 mg/ml PCNA (not
shown), which was about 5-fold higher than the amount used in
DNA replication assays.
Immunoblotting of the hybrids with anti-PCNA antibodies
(65) produced reactivity of PC-9 with CH2, CH3, and CH4, but
not with HC1, HC5, and CH5, whereas PC-10 reacted with
CH2 but did not react with HC1, HC5, CH3, CH4, and CH5
(data not shown). The mutants HU1 and HU3 reacted with
both of the antibodies, as did the wt hPCNA. The reactivity of
these antibodies with the hybrids is consistent to their epitope
locations reported earlier (66).
PCNA Mutants and Hybrids in Solution Can Assemble into
Oligomers—To test whether the PCNA mutants and hybrids
can form trimers in solution we determined their elution profile
on a gel filtration column calibrated with five native proteins of
known molecular sizes. Wt h- and cPCNA preparations sepa-
rated into a major peak corresponding to an apparent molecu-
lar mass of 98 kDa (trimer) and a minor peak corresponding to
29 kDa (monomer). The mutants HU1 and HU3 and hybrids
HC5 and CH3 also gave a major trimer peak and a minor
monomer peak. The hybrids HC1 and CH5 produced more
monomers than trimers, and in CH2 most of protein eluted at
the position of a dimer. The hybrid CH4 had a small proportion
of trimers, but most of the protein eluted in the void volume.
The proportion of oligomeric species in different PCNA prepa-
rations is listed in Table III. The data suggest that in solution
our PCNA preparations, with the exception of CH4, exist in
equilibrium among monomers, dimers, and trimers. Thus our
initial expectation that hybrids of PCNA from the two species
would assemble into trimers was vindicated. However, the
tertiary structure of some of the hybrids was distorted as indi-
FIG. 1. Schematic representation of the polypeptide folding in a native PCNA molecule. Panel A, the elements within the two
topologically identical domains N1 and C1 are labeled using the nomenclature described by Krishna et al. (17). The location of the mutation D21E
in HU1 is shown by an asterisk, which, in the folded structure, lies on the inner surface of the trimeric ring. The mutation D120E in HU3, shown
by a diamond, is located in the IDC loop. Panel B, structure of monomeric PCNA for the wt human, S. cerevisiae, and the hybrids. The hPCNA
polypeptide is shown by a combination of red and pink; cPCNA is shown by a combination of cynol and blue. The N termini of the h- and cPCNA
are shown, respectively, by pink and cynol; the C termini are shown by red and blue.
FIG. 2. Purification of recombinant wt, mutant, and hybrid PCNA from E. coli. Plasmid constructs containing wt, mutant, and hybrid
PCNA were transformed in BL21(DE3) E. coli cells, and protein expression was induced with 1 mM isopropyl-1-thio-b-D-galactopyranoside. The
lysate from a 200-ml culture was adjusted to 0.2 M NaCl, filtered through 0.22 mM before subjecting to Q-Sepharose, S-Sepharose, hydroxyapatite,
and phenyl-Sepharose columns as described under “Experimental Procedures.” The purification of PCNA at various stages of the protocol was
followed by subjecting a small fraction through SDS-PAGE and staining the gel with Coomassie Blue. Panel A, a representative gel of the PCNA
hybrid CH3 during different stages of purification. Panel B, silver-stained SDS gel of the purified PCNA proteins used in this study. A 10-ml sample
containing 3–5 mg of purified PCNA was analyzed in each case.
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cated by a lower proportion of trimers.
The pattern of PCNA oligomerization was investigated fur-
ther by native gel electrophoresis using an Amersham Phar-
macia Biotech Phast System. In this gel system the trimer
band could be clearly distinguished from the fast moving dimer
and monomer bands (45). Consistent with our gel filtration
data we observed trimeric species in the wt h- and cPCNA,
HU1, HU3, HC5, and CH3. The HC1 hybrid remained predom-
inantly a monomer, and CH5 was a mixture of monomers and
trimers. However, minor PCNA species were not detected in
this system, which could be the result of the low sensitivity of
Coomassie staining. The hybrid CH2 produced a smear with no
defined band for monomers or trimers. This suggested that
trimers in CH2 were unstable and that the PCNA molecule
might spontaneously unfold and refold. CH4 was the only hy-
brid to have large aggregates with no monomer and only traces
of trimer (Fig. 3, in the actual gel a trace of trimer was seen
which is not very clear in the photograph). The aggregates in
CH4 were much more homogeneous in size than for the Y114A
mutation reported earlier (45). The presence of dimers in CH2
and large aggregates in CH4 was established further by ethyl-
ene glycol bis-succinimidyl succinate-induced cross-linking
(data not shown).
Function of Mutants and Hybrids Using PCNA-induced DNA
Polymerase d Activity—The ability of the different PCNA pro-
teins to stimulate calf thymus pol d activity on a synthetic DNA
template was studied. Incubation of pol d with the wt hPCNA
stimulated the enzyme in a dose-dependent fashion as reported
previously (23). Compared with the hPCNA, the wt cPCNA did
not express significant pol d stimulatory activity (Fig. 4). The
two mutants, HU1 and HU3, also stimulated pol d in a dose-
dependent fashion, but they had about 40% stimulatory activ-
ity compared with the wt hPCNA. This is interesting because
the two mutations were located in different regions of the
molecule. The D21E mutation in HU1 is located toward the N
terminus, and the D120E mutation in HU3 is located in the
IDC loop. These two sites appear to play a role in PCNA-
induced stimulation of pol d activity. As shown in Fig. 4, the
hybrids HC1, HC5, CH2, and CH4, did not stimulate pol d, but
CH3 and CH5 stimulated the enzyme in a dose-dependent
fashion. The degree of pol d stimulation by CH3 was similar to
that achieved with hPCNA, whereas CH5 had much reduced
stimulatory activity. The ability of the wt, mutant, and hybrid
PCNA to enhance the processivity of pol d was determined by
analyzing the size distribution of the replication products on
alkaline agarose gel electrophoresis. As shown in Fig. 5, the
hybrids HC1, HC5, CH2, and CH4 did not induce processive
DNA synthesis, which was consistent with them being unable
to interact efficiently with pol d. The PCNA proteins that stim-
ulated pol d, HU1, HU3, CH3, and CH5, appeared processive,
but their activity, except for CH3, was reduced compared with
the wt hPCNA. This suggested that HU1, HU3, and CH5 were
impaired in their initial interaction with pol d but not in the
processive DNA synthesis. The data indicate involvement of
IDC loop and both the N- and C-terminal domains in the
interaction of PCNA with pol d. The processivity of pol d with
CH3 was not very different from that with hPCNA, but it was
certainly more active than the wt hPCNA (see Fig. 5). Taken
together, the data suggest that formation of PCNAzpol d com-
plex involves multiple site interactions.
Most of the PCNA Hybrids Were Active in RF-C-mediated
DNA Clamping—The interaction between RF-C and PCNA in
the presence of DNA and ATP results in ATP hydrolysis and
the formation of a sliding clamp. The ATPase activity of RF-C
is stimulated by PCNA in the presence of primed DNA. The
RF-C ATPase assay thus measures the ability of PCNA to
interact with RF-C and DNA. We examined the loading of
PCNA mutants and hybrids onto primed DNA by RF-C. The
assay was conducted at four different PCNA concentrations
(100, 200, 400, and 800 ng) and to compare the data from
different sets, the PCNA-dependent stimulation of RF-C
ATPase activity for different preparations was expressed as
percentage of the wt hPCNA (Fig. 6). The RF-C stimulation
with cPCNA was similar to that in the absence of PCNA,
suggesting that cPCNA was inactive in this assay. All PCNA
hybrids tested showed PCNA-dependent stimulation of RF-C
ATPase, but to different extents. The least stimulation was
TABLE III
Ratio of monomeric, dimeric, and trimeric PCNA recovered from gel
filtration column
PCNA proteins Trimersa Dimersa Monomersa
hPCNA 72 6 22
CPCNA 77 8 15
HU1 67 11 22
HU3 67 10 23
HC1 25 17 58
HC5 63 13 24
CH2 16 53 31
CH3 56 22 22
CH4b 21 0 0
CH5 40 6 54
a Percentage of total protein applied onto the column.
b Most of the protein (about 80%) eluted with the void volume.
FIG. 3. Analysis of PCNA proteins
on a native gel. Wt PCNA (h- and
cPCNA), mutants (HU1 and HU3), and
the hybrid proteins were dialyzed in
buffer A containing 25 mM NaCl and 20%
glycerol. 1 mg of each PCNA protein and
molecular markers were taken in 8 ml of
loading buffer, and 4 ml of this mixture
was run on an 8–25% polyacrylamide gel
for 45 min and stained with Coomassie
Blue. Lanes M1 and M2 indicate native
protein markers: thyroglobulin (669 kDa),
ferritin (440 kDa), catalase (232 kDa), lac-
tate dehydrogenase (140 kDa), BSA (67
kDa), and ovalbumin (45 kDa).
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seen with the hybrids HC1 and HC5, both showing about 10%
of PCNA-dependent RF-C stimulation compared with the wt
hPCNA. The two mutants HU1 and HU3 and the other hy-
brids, CH2, CH3, and CH5, with the exception of CH4,
achieved 40–70% of RF-C stimulation. As with the wt PCNA,
the percentage of RF-C stimulation did not increase with
PCNA concentration for any of the hybrid PCNA preparations,
except for the hybrid CH4. In CH4 the PCNA-dependent stim-
ulation of RF-C ATPase was proportional to the PCNA concen-
tration and was much higher than for the wt hPCNA.
To determine the ATP turnover for the interaction of RF-C
with PCNA, we performed RF-C ATPase assays at 800 ng of
PCNA for 15 and 30 min. Previous studies (9, 23, 67) have
shown that an incubation of 30 min was sufficient for ATP
hydrolysis during RF-CzPCNAzDNA complex formation. Al-
though an incubation of 30 min was sufficient for ADP produc-
tion to reach steady state, the level of ATPase activity with
mutants and hybrids, with the exception of CH4, was less
compared with hPCNA (data not shown). This is consistent
with the dose-dependent experiments described above and
shows that the PCNA preparations, with the exception of HC1
and HC5, were active in RF-C dependent clamping of DNA.
PCNA Mutants HU1 and HU3 Showed Diminished Ability to
Complement M13 DNA Replication in Vitro—Having shown
the effects of the mutants and hybrids on both pol d stimulation
and RF-C loading, we tested their ability to support replication
of a singly primed circular DNA, M13mp18. In this reaction
assembly of the holoenzyme is achieved, and the assay meas-
ures the overall interaction of PCNA with RF-C and DNA as
well as with pol d. From the incorporation of [32P]dAMP, for-
mation of a quaternary complex of wt hPCNA with RF-C, pol d,
and the DNA was evident. The cPCNA was inactive in this
assay (Fig. 7A). The mutants HU1 and HU3 supported DNA
replication, but the hybrids were inactive. The overall activity
of both mutants was similar to each other but only about 30%
compared with the wt hPCNA. However, an analysis on an
alkaline agarose gel revealed that the replication products with
HU1 were shorter than those obtained with hPCNA (Fig. 7B).
HU3 replication products were even shorter than with HU1,
and they resembled those described previously when PCNA or
RF-C was omitted from the replication reaction (9, 25). Clearly,
FIG. 4. Function of PCNA variants with calf thymus DNA pol d
as determined by PCNA-induced stimulation of DNA polymer-
ase activity. Reactions were carried out as described under “Experi-
mental Procedures” with increasing concentrations of PCNA, and in-
corporation of radioactivity after incubation at 37 °C for 15 min was
determined by spotting 2 ml of the reaction mixture on DE81 paper. The
amount of dTMP (in pmol) polymerized was plotted against the amount
of PCNA used in the reaction. Each graph in panels A, B, and C
represents results of a minimum of at least three independent experi-
ments. The standard error bars represent 95% confidence intervals on
the means. The PCNA proteins used in different reactions are shown by
individual symbols in each graph.
FIG. 5. Effect of PCNA mutants and hybrids on the processiv-
ity of DNA pol d. In this set of experiments the reaction components
were adjusted such that the dTMP incorporation corresponded to a
DNA synthesis of less than 0.3 nucleotide from each primer end. A
reaction mixture containing 0.5 ng of the indicated PCNA protein,
0.0075 unit of pol d, and 1.7 pmol of [a-32P]TTP in a total volume of 50
ml was incubated at 37 °C for 15 min. The products were analyzed on a
2% agarose gel under alkaline conditions and revealed by autoradiog-
raphy. The length of the products represents the processivity of DNA
pol d in the presence of indicated PCNA proteins. Lane M contained
DNA fragments obtained with lDNA digested with HindIII, and NP
was a control reaction without PCNA.
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the effect of mutation in HU3 was more dramatic than in HU1
and highlighted the role of the IDC loop in the assembly of the
pol d holoenzyme. Furthermore, the inability of CH3 and CH5
hybrids to induce DNA synthesis in this assay suggests that
the intermolecular interactions at a replication fork are per-
haps not the same as those required for the stimulation of pol
d and RF-C using synthetic substrates.
Human-S. cerevisiae PCNA Hybrids Were Inactive in SV40
DNA Replication in Vitro—A more functional characterization
of the PCNA mutants and hybrids was carried out by reconsti-
tuting SV40 DNA replication in vitro with purified PCNA and
partially fractionated cell extracts. In the reconstitution experi-
ments, replication of DNA was dependent on the presence of
large T antigen and the SV40 origin of replication, indicating
that replicative rather than repair synthesis was occurring
(data not shown). The level of DNA synthesis achieved by the
mutants and hybrids was determined from the amount of
dAMP (in pmol) incorporated during a 1-h incubation. None of
the mutants, hybrids, or the cPCNA attained a level of repli-
cation achieved with the wt hPCNA (Fig. 8). Analysis of the
replication products on an agarose gel revealed three different
categories, A, B, and C (Fig. 8). The replication products with
hPCNA and HU1 shown in category C were almost identical.
HU3 and cPCNA gave rise to replication products similar to
those reported due to uncoupled leading strand synthesis (Fig.
8; group B). Hybrids HC1, HC5, CH2, CH3, CH4, and CH5 did
not support DNA replication, and the products seen were due to
pol a-primase activity (Fig. 8; group A). Thus the wt hPCNA
and HU1 were able to accomplish complete DNA synthesis, and
HU3 and the hybrids were inactive.
FIG. 6. Characterization of RF-C ATPase activity induced by PCNA mutants and hybrids. The RF-C-catalyzed ATPase assays were
performed in a 20-ml reaction containing 0.4 mmol of hairpin DNA and 0.25 pmol of RF-C as described under “Experimental Procedures.” The
amount of ADP produced by RF-C in the absence of PCNA (NP) and in the presence of increasing amounts (100, 200, 400, and 800 ng) of each of
the PCNA protein after incubation at 37 °C for 1 h was determined using a Storm 860 PhosphorImager. The degree of stimulation of RF-C ATPase
activity by different PCNA preparations was compared with the wt hPCNA. The activity of hPCNA under identical conditions was taken as 100%.
FIG. 7. Influence of PCNA mutants and hybrids on M13 DNA replication in vitro. DNA synthesis on singly primed M13 template was
carried in 30 mM HEPES/KOH pH 7.5 buffer, 7 mM MgCl2, 50 mM NaCl, and 1 mM DTT using 4 mg/ml M13mp18 DNA, 10 ng of pol d, 10 mg/ml
RPA, and 1 unit of RF-C in a 20-ml reaction mixture with a 20 mg/ml concentration of the indicated PCNA. Panel A, amount of dAMP (in pmol)
incorporated in the presence of different PCNA proteins. Panel B, replication products were analyzed on a 2% agarose gel run under alkaline
conditions and visualized by autoradiography. Lanes 1 and 2 contained DNA fragments of known sizes by digesting lDNA with Bst II and the
plasmid pBR322 with MspI, respectively. Lane NP shows the reaction products in the absence of PCNA. Lanes hPCNA and cPCNA contained,
respectively, the wt human and S. cerevisiae PCNAs. The single-stranded full-length linear DNA (ssL) and a possible pause site (I) are shown by
arrows.
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We also investigated the possibility that complete DNA rep-
lication in these reactions might be PCNA dose-dependent,
hence the replication reactions were carried out at three differ-
ent concentrations of five of the PCNA hybrids. No obvious
difference was observed in any of the reactions with increasing
amounts of PCNA (data not shown). This suggested that the
lack of complete DNA replication described above was not
caused by insufficient amounts of PCNA in these assays.
DISCUSSION
Previous mutagenesis studies have shown that deletion of
any part of PCNA can distort its tertiary structure, rendering
it incapable of association into trimers. Taking a lead from
previous work, where cPCNA was unable to complement
hPCNA in SV40 DNA replication in vitro (53), when both
proteins existed as trimers in solution (17, 55), we hypothesized
that hybrids of the two proteins would be equivalent to large
deletions within hPCNA without disrupting the trimeric ring.
This would allow identification of functional regions in hPCNA
involved in the assembly of the pol d holoenzyme at a replica-
tion fork. We therefore produced two human PCNA mutants,
HU1 (D21E) and HU3 (D121E), and six hybrids of human and
S. cerevisiae PCNA (see Fig. 1). We have characterized these
proteins for their ability to oligomerize and interact with DNA,
pol d, and RF-C using M13 and SV40 DNA replication in vitro.
From the crystal structure of PCNA, the intermonomer in-
teractions involving bI1 and bD2 sheets appear important in
trimer formation (17, 55). Consequently, mutations located in
bI1, such as Y114A in hPCNA (45) and S115P in cPCNA (46),
are reported to disrupt trimer formation. However, trimer for-
mation by CH3 suggests that the presence of the bD2 sequence
of human and the bI1 of S. cerevisiae at the intermonomer
interface does not interfere with trimeric structure. In CH3,
almost the complete domain 1 of cPCNA was fused to domain 2
of hPCNA. However, replacing bA2, bB2, and bC2 sheets of
hPCNA in CH3 by the corresponding sheets of cPCNA, as in
CH4, distorted the tertiary structure (Figs. 1 and 3). Similarly,
replacing the N-terminal sequences as in CH2 and HC1 led to
a lower proportion of trimers. These data indicate that in-
tramolecular interactions between certain b sheets of h- and
cPCNA in domain 1 and 2 may not be compatible with trimer
formation. The C terminus of hPCNA in CH5 gave a higher
proportion of monomers than the converse hybrid HC5, indi-
cating a role for the C terminus in monomer-trimer equilib-
rium. The N and C termini in PCNA are buried into the
structure, and deletion of these residues (23, 44) or replacing
them by another PCNA sequence, as described in this study, is
likely to disrupt inter-b sheet interactions. Our data are there-
fore consistent with a recent study where mutations L68S and
G69D in bF1 of Schizosaccharomyces pombe PCNA (pPCNA)
produced only dimers, suggesting that other parts of the mol-
ecule, besides intermonomer interface, play a role in the stabi-
lization of trimers (51).
The two mutants HU1 and HU3 stimulated pol d and RF-C
by about 40% compared with the wt hPCNA (see Figs. 4 and 6),
suggesting a role for Asp-21 and Asp-120 in these interactions.
The mutation D21E in HU1 is located just outside aA1, and
this region has never been implicated in pol d or RF-C stimu-
lation. In the crystal structure, however, Asp-21 is close to the
central loop (41DSSHV45), which is shared by pol d and RF-C
(23, 24). Furthermore, the proximity of Asp-21 to helix aA1,
which formed part of the central ring for DNA clamping, might
also affect pol d and RF-C stimulation. The mutation D120E in
HU3 was part of IDC loop (118MDLDVEQLGIPEQEYSC134),
which has been implicated in pol d stimulation in several stud-
ies (23, 49). However, the IDC loop by itself was not sufficient
for pol d stimulation because the hybrid HC5 containing the
IDC loop of human origin was inactive. More than 50% reduc-
tion in RF-C stimulation with HU3 may indicate a role for the
IDC loop in RF-C-induced clamping. Involvement of the IDC
loop in RF-C stimulation has not been suggested in the litera-
ture. However, a mutation close to the IDC loop, A112T, and
another within the loop, S135F, have been shown to suppress
the cold-sensitive mutants in Cdc44p, the largest subunit of S.
cerevisiae RF-C (67). Although the mechanism for the suppres-
sion of cdc44 cold sensitivity is not clear, the data indicate a
role for the IDC loop in the process.
All hybrids were able to assemble into trimers, albeit to
different extents, but only CH3 and CH5 stimulated pol d. The
hybrid CH5, with the last 50 amino acids replaced by the
corresponding region of the hPCNA (see Fig. 1), stimulated pol
d, but the converse hybrid HC5 was inactive. This indicates
that the C-terminal region of hPCNA was a high affinity site
for pol d. This is consistent with previous work where the pol d
binding site in hPCNA (23) and in pPCNA (68, 69) has been
located at the C terminus. However, the inability of CH2 and
CH4 to stimulate pol d when both had a C-terminal sequence of
hPCNA could be due to a lower proportion of trimers in these
preparations (see Fig. 3). This suggests that a certain propor-
tion of PCNA trimers in solution was necessary in addition to a
pol d binding site for effective polymerase stimulation. It is
interesting to note that hybrid CH3, which formed perfect
trimers, also showed high pol d stimulation and appeared to be
more active than the wt hPCNA (see Figs. 1, 4, and 5). A PCNA
mutant with such characteristics has not been described in the
literature. The pol d stimulation assay measures the interac-
tion of PCNA with pol d and the DNA in the absence of RF-C.
The interaction of PCNA with DNA depends on the charge
distribution on the central helices in PCNA which is conserved
across species. All trimeric PCNA hybrids would have DNA
clamping similar to hPCNA. The much higher pol d stimulatory
FIG. 8. Influence of PCNA mutants and hybrids on the SV40
DNA replication in vitro. The SV40 DNA replication in vitro was
performed using S100 cell extract, fractions IA, II, purified large T
antigen, and a SV40 origin containing plasmid pSV011 as described
under “Experimental Procedures” with different PCNA proteins indi-
cated in the figure. PCNA was mixed with 6 mg/ml pSV011, 600 mg/ml
fraction II, 79 mg/ml large T antigen, 900 mg/ml fraction IA, 40 mM
HEPES, pH 8, 8 mM MgCl2. 0.5 mM DTT, 25 mM dATP, 0.1 mM each
dCTP, dGTP, dTTP, 3 mM ATP, 0.2 mM CTP, GTP, UTP, 40 mM creatine
phosphate, 0.12 unit creatine phosphokinase in a total volume of 12.5
ml. The samples were incubated at 37 °C for 1 h, and the controls were
left on ice. After stopping the reaction with 20 mM EDTA, the mixture
was freed of proteins, and the replication products were analyzed on an
agarose gel. The gel was fixed, dried, and autoradiographed. Lane M
refers to lHindIII DNA size markers. NP is a control reaction in the
absence of PCNA. The replication products were classified into groups
A, B, and C based on the pattern seen on the gel.
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activity associated with CH3 could therefore indicate a stretch
of cPCNA in CH3 acquiring a conformation with much higher
affinity for pol d.
The data on RF-C stimulation with CH2, CH3, and CH5
suggest that increasing the proportion of cPCNA sequence does
not change the ATPase activity, implying that the major RF-C
binding was located at the C terminus (Fig. 6 and Table II).
This is consistent with previous mutagenesis studies (23, 70).
However, the C terminus of neither pPCNA (68) nor cPCNA
(48) contains a RF-C binding site, which is consistent with our
finding that the hybrids HC1 and HC5 with the C terminus of
cPCNA showed the least RF-C binding (see Fig. 6). For RF-C
stimulation, the conformation of residues rather than a trim-
eric structure appears to be more important. For instance, the
hybrid CH2 that was predominantly a dimer in solution ex-
pressed RF-C stimulation as much as by HU1, HU3, and CH5,
which were mainly trimeric (Fig. 6). This suggests that a tri-
meric PCNA may not be a prerequisite for RF-C-mediated
clamping of DNA. However, it is possible that binding of RF-C
to PCNA could induce trimeric assembly and subsequent
clamping. Jonsson et al. (45) have shown that Y114A PCNA
aggregates did not compete with the trimeric PCNA for pol d
and RF-C, and based on this they concluded that RF-C did not
have a role in aiding trimer formation. However, it may be that
for RF-C to aid trimer assembly the RF-C binding must be
preserved, and the aggregated PCNA might have lost these
sites. Although monomeric PCNA mutants have been shown
inactive in RF-C mediated clamping in vitro (23, 46), one of
them, S115P, assembled the pol d holoenzyme in the presence
of 6% polyethylene glycose and also supported S. cerevisiae cell
growth, suggesting that nontrimeric PCNAs that have retained
their ability to associate can be loaded by RF-C (46). RF-C-
induced loading of CH2 as shown in this study indicates that
RF-C can sequester nontrimeric PCNA in presence of DNA.
RF-C-mediated loading of the two dimeric mutants L68S and
G69D described recently is not known as they were not used in
the loading assay (51). The basis for the very high PCNA-de-
pendent RF-C ATPase activity observed in the PCNA hybrid
CH4 is not clear. It could be caused by structural alterations
introduced by swapping over the polypeptide segments.
Assembly of the pol d holoenzyme complex at a replication
fork is a reflection of the ability of PCNA to load on to DNA by
RF-C and subsequent association of pol d into a highly proces-
sive enzyme. Thus interaction among different components of
the ternary complex including RF-C, PCNA, pol d, and DNA
can be measured in one holoenzyme assay. Using the M13
replication assay we found that only HU1 supported some
replicative activity, whereas HU3 along with the hybrids was
inactive. This indicated that stimulation of pol d and RF-C-
induced DNA clamping by the mutants and hybrids CH3 and
CH5 could not activate DNA synthesis at a replication fork. It
may be argued that hybrids CH3 and CH5 cannot interact
simultaneously with pol d and RF-C in this assay because
identical sites are involved. However, pol d and RF-C do inter-
act simultaneously with the wt hPCNA perhaps because they
can share redundant structure, which may be lost in the hy-
brids. Another possibility could be that assembly of the pol d
holoenzyme involves binding of other proteins and that loss of
this binding in the hybrids could block DNA synthesis. Involve-
ment of other proteins in holoenzyme assembly has been sus-
pected previously from the IDC loop mutants unable to interact
with pol d but had no influence on DNA replication (48). Be-
sides PCNA, pol d, and RF-C, the only other protein in M13
assay is RPA. Although a direct interaction between RPA and
PCNA has not been reported, a recent study has shown that
RPA forms a common touch-point with pol d, RF-C, and PCNA
at a replication fork. Among these, an association of RPA with
the RF-CzPCNA complex has been proposed to play an impor-
tant role for the holoenzyme function (71). It is possible that the
complex between RF-C and PCNA mutants or hybrids acquires
a conformation that is not compatible with RPA binding. Al-
ternatively, RPA may have cryptic sites for PCNA which are
accessible only at the replication fork. Incomplete accessibility
of these sites in PCNA variants could have prevented RPA
binding. Our results therefore suggest a role of RF-C and RPA
far beyond loading of PCNA and coupling the unwinding of the
double helix with the initiation of DNA synthesis (72, 73). The
results from SV40 DNA synthesis were similar to the M13
assay except for HU1, which was more active in SV40 than in
the M13 assay. The discrepancy between the two assays could
be caused by a factor(s) in the SV40 reaction mixture able to
compensate for the loss of binding in the M13 assay. This is
likely given the fact that SV40 DNA replication required a far
more complex mixture of proteins. Taken together, the data
from SV40 and M13 DNA replication assays suggest that the
PCNA hybrids and the mutant HU3 were unable to assemble a
functional DNA pol d holoenzyme.
The three sites that we have identified on hPCNA located on
N- and C-terminal regions and the IDC loop appear to play an
important role in the stimulation of pol d, RF-C, and also in the
assembly of the holoenzyme. Besides PCNA, the proteins in-
volved in the holoenzyme assembly pol d, RF-C, and RPA are
oligomers of heterosubunits. Mammalian DNA pol d is an oli-
gomer of three different subunits, 125 kDa, 48 kDa, and a
recently identified 66-kDa subunit (74). RF-C has five sub-
units, 140, 36, 37, 38, and 40 kDa, but only the largest subunit
binds PCNA (57). RPA is also a heterotrimer of p70, p34, and
p11 (75). PCNA provides a platform for dynamic assembly and
disassembly of these proteins at a replication fork. To enable an
ordered flow of events during DNA replication it is perhaps
important that there is more than one binding site for each
protein on PCNA.
In summary, we have shown that the trimeric structure of
PCNA is maintained by associations among several b sheets
located in domains 1 and 2 of the molecule. We have identified
three regions on hPCNA, located at the N- and C-terminal
domains and the IDC loop, which are required to stimulate pol
d and RF-C activity, but the site at the C-terminal domain
appears to be the high affinity site for the two proteins. Inter-
estingly, PCNA dimers, which were inactive in pol d stimula-
tion but showed significant RF-C-induced loading, suggested
that trimeric PCNA may not be a prerequisite for RF-C-medi-
ated clamping of DNA. Our data indicate participation of other
proteins, one of them could be RPA, for successful DNA syn-
thesis at a replication fork. The identification and roles of these
proteins at a replication fork will enable us to have a complete
understanding of the biochemical steps necessary for the as-
sembly of pol d holoenzyme.
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